chr19-7860678-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001159944.3(EVI5L):c.1492G>A(p.Asp498Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000378 in 1,586,798 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000053 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000036 ( 0 hom. )
Consequence
EVI5L
NM_001159944.3 missense
NM_001159944.3 missense
Scores
2
7
10
Clinical Significance
Conservation
PhyloP100: 7.87
Genes affected
EVI5L (HGNC:30464): (ecotropic viral integration site 5 like) Enables GTPase activator activity and small GTPase binding activity. Involved in negative regulation of cilium assembly and positive regulation of GTPase activity. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.22335735).
BS2
High AC in GnomAd4 at 8 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EVI5L | NM_001159944.3 | c.1492G>A | p.Asp498Asn | missense_variant | 14/20 | ENST00000538904.7 | NP_001153416.1 | |
EVI5L | NM_145245.5 | c.1459G>A | p.Asp487Asn | missense_variant | 13/19 | NP_660288.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EVI5L | ENST00000538904.7 | c.1492G>A | p.Asp498Asn | missense_variant | 14/20 | 1 | NM_001159944.3 | ENSP00000445905.1 | ||
EVI5L | ENST00000270530.8 | c.1459G>A | p.Asp487Asn | missense_variant | 13/19 | 1 | ENSP00000270530.3 | |||
EVI5L | ENST00000601766.1 | c.94G>A | p.Asp32Asn | missense_variant | 1/4 | 3 | ENSP00000470145.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152216Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
8
AN:
152216
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000295 AC: 6AN: 203664Hom.: 0 AF XY: 0.0000183 AC XY: 2AN XY: 109528
GnomAD3 exomes
AF:
AC:
6
AN:
203664
Hom.:
AF XY:
AC XY:
2
AN XY:
109528
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000363 AC: 52AN: 1434464Hom.: 0 Cov.: 30 AF XY: 0.0000352 AC XY: 25AN XY: 710928
GnomAD4 exome
AF:
AC:
52
AN:
1434464
Hom.:
Cov.:
30
AF XY:
AC XY:
25
AN XY:
710928
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152334Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74498
GnomAD4 genome
AF:
AC:
8
AN:
152334
Hom.:
Cov.:
33
AF XY:
AC XY:
5
AN XY:
74498
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
5
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2023 | The c.1492G>A (p.D498N) alteration is located in exon 13 (coding exon 13) of the EVI5L gene. This alteration results from a G to A substitution at nucleotide position 1492, causing the aspartic acid (D) at amino acid position 498 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;.
PrimateAI
Pathogenic
T
PROVEAN
Uncertain
D;D;.
REVEL
Benign
Sift
Uncertain
D;D;.
Sift4G
Benign
T;T;D
Polyphen
D;.;.
Vest4
MVP
MPC
1.4
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at